Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOLIFE SOLUTIONS INCBLFS · Entity 4614 | Chief Revenue Officer | May 28, 2020 | June 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOLIFE SOLUTIONS INC
Report date May 28, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,856 |
Reported balance
After 2020-05-28 transaction · row 1
1 source rowRow 1 · 2020-05-28 · Sale · Disposed 121 · Balance 19,856 F1: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $14.06 | $35,150.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.57 | $38,925.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.531 to $15.691, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.69 | $41,725.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| November 12, 2019 Filed Nov 15, 2019 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-022980 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.89 | $42,225.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.87 to $16.95, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $17.44 | $43,600.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.3803 to $17.58, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $17.31 | $43,275.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| October 29, 2019 Filed Nov 1, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-021117 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,693 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,113 Underlying: Common Stock · 2,693 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,693 | $16.42 | $44,219.06 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,077 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.38 to $16.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,693 | $1.64 | $4,416.52 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,307 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,806 Underlying: Common Stock · 2,307 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,307 | $16.03 | $36,981.21 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.02 to $16.145, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,307 | $1.64 | $3,783.48 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.06 | $40,150.00 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.06 to $16.07, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 01:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-020230 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.15 | $40,375.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.16, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.78 | $39,450.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.75 to $15.90, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.53 | $41,325.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.51 to $16.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2019 Filed Oct 4, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-019662 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $20.80 | $52,000.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.77 to $20.81, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $20.95 | $52,375.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $20.17 | $50,425.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.17 to $20.20, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 17, 2019 Filed Sep 20, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-018771 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-017956 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $20.11 | $50,275.00 |
DisclosureSEC source: 0001437749-19-017956 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.21, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-017956 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-017956 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.